Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1483645

registered interest
date	27/06/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that breast cancer patients begin their treatment within a maximum of 62 days of an urgent GP referral.
tabling member constituency	Slough
tabling member printed	Mr Tanmanjeet Singh Dhesi
uin	25977
answer	answer is ministerial correction date of answer 04/07/2022 answer text <p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ states that the number of patients waiting more than 62 days to start treatment from an urgent referral for cancer will return to pre-pandemic levels by March 2023. We are providing more than £8 billion from 2022/23 to 2024/25 to support the recovery of elective services, including cancer treatment. This is in addition to the existing £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund.</p><p> </p><p>This investment is also supporting the launch of community diagnostic centres which will deliver additional capacity for co-ordinated diagnostic checks, enabling faster diagnosis on a range of a clinical pathways, including cancer.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 25975 question first answered 04/07/2022 12:58:06 answering member 4492 label Biography information for Maria Caulfield
tabling member	4638 label Biography information for Mr Tanmanjeet Singh Dhesi

1342985

registered interest
date	01/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgical Mesh Implants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government has plans to investigate a potential link between the properties of polypropylene mesh and foreign body reaction, fibromyalgia and autoimmune disorders.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Aaron Bell
uin	25977
answer	answer is ministerial correction date of answer 17/08/2021 answer text <p>There are no plans to investigate the link between the properties of polypropylene mesh and foreign body reaction, fibromyalgia and autoimmune disorders.</p><p>The Department has commissioned NHS Digital to undertake a retrospective audit of complications from pelvic mesh from a defined cohort of women. This was announced in the Government’s response to the Independent Medicines and Medical Devices Review.</p><p>Planning is at an early stage and the requirements for this audit are currently being gathered from a range of stakeholders and patient representatives.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 17/08/2021 15:55:29 answering member 1481 label Biography information for Ms Nadine Dorries previous answer version 12670 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4837 label Biography information for Aaron Bell